(VIANEWS) – CELYAD ONCOLOGY (BEL 20: CYAD.BR) fell 9.81% to EUR0.96 at 15:18 EST Monday afternoon after four straight sessions of gains, while the BEL 20 was down 0.35% at EUR3,670.13, signalling an overall downward trend for today’s trading session. About CELYAD ONCOLOGY Celyad Oncology SA is a clinical-stage biopharmaceutical company focused on the research…
(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session. The three biggest winners today are CELYAD ONCOLOGY, ENSURGE MICROPOWER, and MKB Nedsense. Financial Asset Price Change Updated (EST) CELYAD ONCOLOGY (CYAD.BR) 0.98 30.85% 2023-09-01 12:07:16 ENSURGE MICROPOWER (ENSU.OL) 0.13 12.17%…
(VIANEWS) – The Market ended the session with CELYAD ONCOLOGY (CYAD.BR) rising 30.85% to €0.98 on Friday while BEL 20 jumped 0.46% to €3,682.86. About CELYAD ONCOLOGY Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead…
(VIANEWS) – CELYAD ONCOLOGY (BEL 20: CYAD.BR) shares surged 30.85% to EUR0.98 at 15:30 EST Friday, building on two consecutive sessions of gains and extending an earlier uptrend by 0.06% to EUR3,668.26; this trend suggests positive momentum so far. About CELYAD ONCOLOGY Celyad Oncology is a clinical-stage biopharmaceutical company specializing in CAR-T cell therapy for…
(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session. The three biggest winners today are AUGROS COSMETICS, ORAPI, and CELYAD ONCOLOGY. Financial Asset Price Change Updated (EST) AUGROS COSMETICS (AUGR.PA) 7.80 15.56% 2023-08-08 11:37:04 ORAPI (ORAP.PA) 6.40 12.68% 2023-08-08 11:01:06…
(VIANEWS) – The Market ended the session with CELYAD ONCOLOGY (CYAD.BR) rising 10% to €0.57 on Tuesday, following the last session’s upward trend. BEL 20 dropped 0.46% to €3,699.10, following the last session’s downward trend on what was a somewhat bearish trend trading session today. About CELYAD ONCOLOGY Celyad Oncology SA, a clinical-stage biopharmaceutical company,…
Celyad Oncology’s (CYAD.BR) stocks experienced an unexpected surge on the BEL 20 market index on Tuesday. The company saw a ten percent increase in their stock’s value, climbing up to EUR0.57. This substantial rise starkly contrasted the overall market trend which followed a downward trajectory, with the market index falling by 0.3% to EUR3,704.94. Hence,…
(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session. The three biggest winners today are NANOBIOTIX, MEMSCAP REGPT, and OCEANTEAM. Financial Asset Price Change Updated (EST) NANOBIOTIX (NANO.PA) 7.59 11.13% 2023-08-07 11:00:45 MEMSCAP REGPT (MEMS.PA) 5.46 9.2% 2023-08-07 11:00:16 OCEANTEAM…
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) slid 9.09% to €0.52 at 11:10 EST on Monday, following the last session’s downward trend. BEL 20 is jumping 0.16% to €3,742.92, after two consecutive sessions in a row of gains. This seems, up until now, a somewhat positive trend trading session today. About CELYAD ONCOLOGY…
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) dropped by a staggering 27.71% in 21 sessions from €0.83 to €0.60 at 14:08 EST on Tuesday, after two successive sessions in a row of losses. BEL 20 is sliding 1.43% to €3,751.52, after two successive sessions in a row of gains. About CELYAD ONCOLOGY Celyad…
